Company Filing History:
Years Active: 2003-2004
Title: The Innovative Contributions of Sharon Engel
Introduction
Sharon Engel is a prominent inventor based in Ramat Hasharon, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of novel nucleic acid and amino acid sequences. With a total of 3 patents to her name, Engel's work has the potential to impact various medical applications.
Latest Patents
Engel's latest patents include groundbreaking inventions such as the VEGF nucleic acid and amino acid sequences. This invention focuses on novel sequences of a variant of vascular endothelial growth factor (VEGF), which are crucial for understanding and treating various diseases. Additionally, her patent on alternative splice variants of CD40 presents new nucleic acid sequences and amino acid sequences obtained through alternative splicing, along with expression vectors and pharmaceutical compositions that utilize these sequences.
Career Highlights
Sharon Engel is currently associated with Compugen Ltd., a company known for its innovative approaches in the field of biotechnology. Her work at Compugen has allowed her to explore and develop cutting-edge technologies that contribute to advancements in medical research and treatment options.
Collaborations
Engel collaborates with talented individuals such as Liat Mintz and Kinneret Savitzky, who share her passion for innovation and research. Together, they work towards achieving breakthroughs that can lead to significant improvements in healthcare.
Conclusion
Sharon Engel's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her innovative work continues to pave the way for advancements in medical science and technology.